Common menopause medication might prevent breast cancer while treating hot flashes

Common menopause medication might prevent breast cancer while treating hot flashes

Some women with higher cancer risk could benefit from combination drug, but more research is needed

A drug intended to treat menopause symptoms could double as breast cancer prevention, new research suggests. (iStock)

Ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, affects more than 60,000 U.S. women each year. (iStock)

Post-menopausal patients who took the CE/BZA reported fewer hot flashes during the study. (iStock)